ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

NTP Board Approves Four New Concepts

October 8, 1982

Thompson Tours Brown’s Brain Science Center.

March 16, 2001

Fund Squeeze Results In Percentage reductions for Renewed Program Project, Center Core Grants

April 8, 1977

NCI Asks Centers To Limit Increases In Applying For Support Grant Renewals.

October 12, 2001

Society Develops Guidelines For Integrative Oncology

August 31, 2007